Unknown

Dataset Information

0

Proteomic Biomarkers of the Apnea Hypopnea Index and Obstructive Sleep Apnea: Insights into the Pathophysiology of Presence, Severity, and Treatment Response.


ABSTRACT: Obstructive sleep apnea (OSA), a disease associated with excessive sleepiness and increased cardiovascular risk, affects an estimated 1 billion people worldwide. The present study examined proteomic biomarkers indicative of presence, severity, and treatment response in OSA. Participants (n = 1391) of the Stanford Technology Analytics and Genomics in Sleep study had blood collected and completed an overnight polysomnography for scoring the apnea−hypopnea index (AHI). A highly multiplexed aptamer-based array (SomaScan) was used to quantify 5000 proteins in all plasma samples. Two separate intervention-based cohorts with sleep apnea (n = 41) provided samples pre- and post-continuous/positive airway pressure (CPAP/PAP). Multivariate analyses identified 84 proteins (47 positively, 37 negatively) associated with AHI after correction for multiple testing. Of the top 15 features from a machine learning classifier for AHI ≥ 15 vs. AHI < 15 (Area Under the Curve (AUC) = 0.74), 8 were significant markers of both AHI and OSA from multivariate analyses. Exploration of pre- and post-intervention analysis identified 5 of the 84 proteins to be significantly decreased following CPAP/PAP treatment, with pathways involving endothelial function, blood coagulation, and inflammatory response. The present study identified PAI-1, tPA, and sE-Selectin as key biomarkers and suggests that endothelial dysfunction and increased coagulopathy are important consequences of OSA, which may explain the association with cardiovascular disease and stroke.

SUBMITTER: Cederberg KLJ 

PROVIDER: S-EPMC9317550 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Proteomic Biomarkers of the Apnea Hypopnea Index and Obstructive Sleep Apnea: Insights into the Pathophysiology of Presence, Severity, and Treatment Response.

Cederberg Katie L J KLJ   Hanif Umaer U   Peris Sempere Vicente V   Hédou Julien J   Leary Eileen B EB   Schneider Logan D LD   Lin Ling L   Zhang Jing J   Morse Anne M AM   Blackman Adam A   Schweitzer Paula K PK   Kotagal Suresh S   Bogan Richard R   Kushida Clete A CA   Ju Yo-El S YS   Petousi Nayia N   Turnbull Chris D CD   Mignot Emmanuel E   The Stages Cohort Investigator Group  

International journal of molecular sciences 20220720 14


Obstructive sleep apnea (OSA), a disease associated with excessive sleepiness and increased cardiovascular risk, affects an estimated 1 billion people worldwide. The present study examined proteomic biomarkers indicative of presence, severity, and treatment response in OSA. Participants (n = 1391) of the Stanford Technology Analytics and Genomics in Sleep study had blood collected and completed an overnight polysomnography for scoring the apnea−hypopnea index (AHI). A highly multiplexed aptamer-  ...[more]

Similar Datasets

| S-EPMC6630080 | biostudies-literature
| S-EPMC7428529 | biostudies-literature
| S-EPMC4539216 | biostudies-literature
| S-EPMC7127992 | biostudies-literature
| S-EPMC10872216 | biostudies-literature
| S-EPMC8376723 | biostudies-literature
2025-04-01 | GSE293433 | GEO
| S-EPMC2913239 | biostudies-literature
| S-EPMC10369631 | biostudies-literature